Investigational Enzyme Replacement Therapy Products: Nonclinical Assessment: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 3, 2019
April 24, 2020
a3c5d661-a82f-441e-9036-1639578d4fc9
Related Documents
Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
Guidance DocumentAugust 2, 2019Center for Drug Evaluation and Research
Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry
Guidance DocumentOctober 28, 2020Center for Drug Evaluation and Research
Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentAugust 15, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox